Bristol-Myers Squibb Company (NYSE:BMY) is among the 15 Best Boring Dividend Stocks to Buy. Bayer’s successful FXIa inhibitor trial results have drawn attention to BMY and similar treatments, though caution remains due to the company’s high payout ratio of around 84%. BMY generated $15.3 billion in free cash flow in the past 12 months.

Investors are concerned about BMY’s long-term dividend safety as the company carries $32 billion in net debt. While this has decreased from earlier in the year, it remains a substantial burden. BMY focuses on discovering, developing, and manufacturing innovative treatments for serious diseases in areas such as oncology, immunology, and cardiovascular conditions.

While BMY shows potential as an investment, some believe AI stocks offer greater upside potential with less downside risk. An undervalued AI stock with potential benefits from Trump-era tariffs and onshoring trends may be worth considering. Check out the 15 Best Long Term Stocks to Buy According to Reddit and 15 Best Stocks to Buy for Medium Term for more investment options.

Read more at Yahoo Finance: BMY Gains Attention as Bayer Reports FXIa Trial Success